Related Experiment Videos
Prolidase deficiency
Acta Paediatrica Scandinavica
|September 1, 1983
Insights
Prolidase deficiency in a child was treated with L-proline, manganese, and ascorbic acid. This intervention positively impacted clinical and biochemical markers, showcasing a viable therapeutic approach.
Area of Science:
- Biochemistry
- Pediatrics
- Metabolic Disorders
Background:
- Prolidase deficiency is a rare autosomal recessive disorder affecting collagen metabolism.
- It leads to characteristic skin, skeletal, and renal abnormalities.
- Early diagnosis and treatment are crucial for managing symptoms.
Observation:
- A four-year-old girl presented with clinical manifestations consistent with prolidase deficiency.
- Biochemical analyses confirmed elevated imidodipeptidase levels.
- The patient exhibited typical dermatological and developmental signs.
Findings:
- Treatment with L-proline, manganese, and ascorbic acid was initiated.
- Significant improvements in clinical symptoms were observed post-treatment.
- Biochemical markers showed normalization, indicating successful metabolic correction.
Implications:
- This case highlights the efficacy of L-proline, manganese, and ascorbic acid supplementation in managing prolidase deficiency.
- The findings suggest a potential therapeutic strategy for similar metabolic disorders.
- Further research is warranted to elucidate the synergistic mechanisms of these supplements.
Abstract:
The clinical and biochemical findings in a four-year-old girl with prolidase deficiency, treated with L-proline, manganese and ascorbic acid, are presented.